Aspirin prescription and outcomes in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS)
about
Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysisAspirin for primary cardiovascular prevention: when is it worth the risks?Low-dose aspirin for prevention of cardiovascular disease in patients with chronic kidney disease.Variation in the level of eGFR at dialysis initiation across dialysis facilities and geographic regionsReconsidering low-dose aspirin therapy for cardiovascular disease: a study protocol for physician and patient behavioral change.Incidence of bleeding from gastroduodenal ulcers in patients with end-stage renal disease receiving hemodialysis.The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modificationsProton Pump Inhibitor Use and Magnesium Concentrations in Hemodialysis Patients: A Cross-Sectional StudyGeographic and facility variation in initial use of non-tunneled catheters for incident maintenance hemodialysis patients.Prediction of Mortality in Incident Hemodialysis Patients: A Validation and Comparison of CHADS2, CHA2DS2, and CCI ScoresContemporary Management of Coronary Artery Disease and Acute Coronary Syndrome in Patients with Chronic Kidney Disease and End-Stage Renal Disease.Consistent aspirin use associated with improved arteriovenous fistula survival among incident hemodialysis patients in the dialysis outcomes and practice patterns studyAnticoagulant and antiplatelet usage associates with mortality among hemodialysis patients.Chronic kidney disease in acute coronary syndromes.Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: the choices for healthy outcomes in caring for ESRD (CHOICE) study.Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: results from the DOPPSAntiplatelet medications in hemodialysis patients: a systematic review of bleeding ratesPeptic ulcer disease risk in chronic kidney disease: ten-year incidence, ulcer location, and ulcerogenic effect of medications.Perioperative management of the hemodialysis patient.Management of chronic kidney disease in the elderly.Stroke and renal dysfunction: are we always conscious of this relationship?Antiplatelet therapy in the management of cardiovascular disease in patients with CKD: what is the evidence?Sudden cardiac death in haemodialysis patients: preventative options.Perioperative Pharmacologic Management of Patients with End Stage Renal Disease.Does pharmacotherapy improve cardiovascular outcomes in hemodialysis patients?Gastrointestinal bleeding in patients with renal failure under hemodialysis treatment: a single-center experience.Dual Antiplatelet Therapy and Clinical Outcomes after Coronary Drug-Eluting Stent Implantation in Patients on Hemodialysis.Antiplatelet agents in hemodialysis.Oral antiplatelet drugs in patients with chronic kidney disease (CKD): a review.Antithrombotic therapy in end-stage renal disease.Aspirin Use and Incident Cardiovascular Disease, Kidney Failure, and Death in Stable Kidney Transplant Recipients: A Post Hoc Analysis of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial.Low-dose aspirin for prevention of cardiovascular disease in patients on hemodialysis: A 5-y prospective cohort study.Reduction of intracerebral hemorrhage in hemodialysis patients after reducing aspirin use: A quality-assurance observational study.Role of Cilostazol Therapy in Hemodialysis Patients with Asymptomatic Peripheral Arterial Disease: A Retrospective Cohort Study.Endoscopic papillary balloon dilation for bile duct stones in patients on hemodialysis.Different peptic ulcer bleeding risk in chronic kidney disease and end-stage renal disease patients receiving different dialysis.Platelet reactivity in stable cardiovascular patients with chronic kidney disease.Feasibility of endoscopic retrograde cholangiopancreatography-related procedures in hemodialysis patients.Effect of low dose aspirin and dipyridamole on primary patency of arteriovenous grafts in hemodialysis patients: a randomized double-blind placebo-controlled trial.Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD).
P2860
Q27002491-7116A70C-B750-4C28-91EC-D72DF5B424ECQ33774734-1ABC9CA4-68DB-45A4-9955-5C9BF9454411Q34005232-BBB7BDEF-4B76-45DA-B6B0-D85F9AFCBEEDQ34292926-3624C447-822F-4006-A65A-08716B14A865Q35121893-9F9C5E4A-9A77-446C-ADBF-F5E8DF8232DAQ35664091-2E02C7C4-2859-4A1D-9A7A-74F616505BC6Q35676161-AF57D2B5-198B-4615-9408-F01CF353E159Q35855528-BC2A1F70-00D8-4EB5-9DA8-A461A6BB4095Q35937884-E2647038-DE66-4448-B7C5-D128E6B27CEAQ36009279-9C148455-A352-4DD2-8AC0-3463F72B6E0BQ36721107-30C14F5B-8D41-4C9D-87A4-08F7114FC07EQ36843438-EA6D7044-988F-477C-8F32-27FFF0A4038AQ37146464-EE55B22F-A2E7-44AC-9F75-D0A6EAC96948Q37195393-CB241528-99DE-429F-B8E4-79F72F36B1ABQ37347775-C4D39122-969B-4061-B7E2-57DC974FF4A6Q37454324-3B13C4CA-47DC-47FE-A100-985F96EA6A2DQ37541521-3A2EB927-18D3-4CBC-A702-C731E75A370FQ37549220-FF756CAE-C684-4506-A422-855384F3F036Q37857339-84756789-2292-4B94-9E81-1154B21B9B05Q37955298-B53A5888-2F57-4EDC-AF7F-5A1E498E693FQ38008318-1400B4EA-37ED-4346-BD95-AA149F36DC7DQ38048245-21481D77-87C4-4D36-9860-EEE0F282469DQ38250885-A62DF596-FAB6-42A3-A402-C41F10BEF623Q38422065-0175A748-432D-4CC0-B455-6EDC88381ABBQ38602442-7DEFC6FA-96F0-44E6-9234-81DD748FABBAQ38765699-16CF8A66-AD86-464F-888F-ECD2F539BB18Q38973363-89FC8383-A2B4-4AEE-9D37-43F63BEB5939Q39032565-FBF40337-F8FE-42A6-8619-02A3643749A7Q39147420-F6C71A17-50DB-4761-AF3D-547F662E8566Q39329927-53E08565-4E94-40A0-BE93-BBACDADBCB22Q40869549-9F93EE71-56FD-4250-B31B-4ECA807593F5Q40877690-6D67C8C5-3ACC-4D28-A18E-4636E906730CQ42368986-E0CFFDE7-A984-441D-8A91-CBC1375F1589Q42385835-FF6FDC79-E9BC-44E3-91F6-624AC88011EAQ43746288-B6DC7A10-4D12-4611-9C7B-5D7786CC35DFQ45827287-D3EE2214-35E6-44A9-8C21-360CC3392E38Q48329778-DAB1D3D4-A251-4C1A-81C1-27C0788B8802Q50791103-C8916EA6-AC17-4BB7-92FC-A26A3FC7CF30Q55079034-7760C7BB-4431-4FB3-B406-BAE9CBCD4330Q55476982-58FABACE-8EDD-43B0-94BA-37C86E0801CE
P2860
Aspirin prescription and outcomes in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS)
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Aspirin prescription and outco ...... ractice Patterns Study (DOPPS)
@ast
Aspirin prescription and outco ...... ractice Patterns Study (DOPPS)
@en
Aspirin prescription and outco ...... ractice Patterns Study (DOPPS)
@nl
type
label
Aspirin prescription and outco ...... ractice Patterns Study (DOPPS)
@ast
Aspirin prescription and outco ...... ractice Patterns Study (DOPPS)
@en
Aspirin prescription and outco ...... ractice Patterns Study (DOPPS)
@nl
prefLabel
Aspirin prescription and outco ...... ractice Patterns Study (DOPPS)
@ast
Aspirin prescription and outco ...... ractice Patterns Study (DOPPS)
@en
Aspirin prescription and outco ...... ractice Patterns Study (DOPPS)
@nl
P2093
P921
P3181
P1476
Aspirin prescription and outco ...... ractice Patterns Study (DOPPS)
@en
P2093
Brenda W Gillespie
Eric W Young
Jean Ethier
Jennifer L Bragg-Gresham
Luis Piera
Nancy Mason
Tadao Akizawa
Yasushi Asano
P304
P3181
P356
10.1053/J.AJKD.2007.07.007
P407
P577
2007-10-01T00:00:00Z